Chengdu Tiantaishan Pharmaceutical

Chengdu Tiantaishan Pharmaceutical is a prominent Chinese pharmaceutical company headquartered in Chengdu, Sichuan Province. Established in 1993, the company has grown into a comprehensive enterprise specializing in the research, development, and large-scale production of finished dosages and active pharmaceutical ingredients (APIs). Its extensive manufacturing capabilities include GMP-certified lines for large-volume injections, small-volume injections, tablets, capsules, and granules. The company's product portfolio is particularly strong in the areas of cardiovascular and cerebrovascular health, neurology, and anti-infectives, featuring key products such as Oxiracetam and Ginkgo Biloba Extract. As a recognized National High-tech Enterprise, Chengdu Tiantaishan Pharmaceutical plays a significant role in the domestic Chinese healthcare market through its robust supply chain and diverse therapeutic offerings.